Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioblastoma × Platinum × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 4 Uterine Cervical Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Stomach Neoplasms 1 Ovarian Neoplasms 1 Metastatic Solid Tumors 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Temozolomide 11 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Blood Specimen Collection 3 Bevacizumab 3 tislelizumab 2 pembrolizumab 2 Specimen Handling 2 Radiation 2 florbetapir 1 elemene 1 contrast agent BR1 1 cemiplimab 1 X-Rays 1 Vortioxetine 1 Valacyclovir 1 Surgical Procedures, Operative 1 Spironolactone 1 Sampling Studies 1 Radiotherapy, Intensity-Modulated 1 Psychosocial Intervention 1 Platinum 1 Physical Examination 1 Photons 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Lomustine 1 Haloperidol 1 Growth and Development 1 Disulfiram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡